Real-world data of opicapone in patients with Parkinson's disease experiencing motor fluctuations: the OPTIMO study.

Front Neurol · 2026 · PMC12961986 · PMID 41798821

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This observation is in line with the results of a post-hoc analysis of the BIPARK I/II studies in which patients with a shorter disease evolution (duration), lower PD severity, and shorter onset time of the motor fluctuations showed a trend for greater efficacy of opicapone ( 26 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.